Ciprofloxacin
Product Images NDC 67296-1703

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 67296-1703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel10ml (Cartonlabel10ml)

This text is a detailed description of a medication in the form of eye drops. It contains information about the active ingredients, usage instructions, storage recommendations, precautions, dosage instructions, and manufacturer details. The product is intended for topical ophthalmic use, and it is essential to dispense the drops with gentle pressure and avoid touching the dropper tip to any surface to prevent contamination. The medication is distributed by Leading Pharma, LLC and manufactured by FDC Limited in Maharashtra, India. It is recommended to read the enclosed insert for more information.*

FDA Label Image

Cartonlabel2point5ml (Cartonlabel2point5ml)

This is a detailed description of Ciprofloxacin Ophthalmic Solution USP, which contains 3.5 mg of ciprofloxacin hydrochloride per mL. It advises storing the solution at 25 degrees Celsius and mentions the active and inactive ingredients. Instructions on how to use the product by snapping off the dust cover and precautions about not touching the dropper tip to surfaces are provided. The solution is sterile with a preservative and is manufactured in India. The text also includes dosage information and details about the manufacturer, Leading Pharma, LLC.*

FDA Label Image

Cartonlabel5ml (Cartonlabel5ml)

This is a description of an ophthalmic solution containing ciprofloxacin hydrochloride. Each mL contains 3.5 mg of ciprofloxacin hydrochloride, equivalent to 3 mg of ciprofloxacin base. The solution also includes benzalkonium chloride as a preservative and other inactive ingredients. The storage instructions mention to store the solution at 25°C, with excursions permitted between 15-30°C. It is advised to dispense the drops with gentle pressure and avoid touching the dropper tip to any surface to prevent contamination. Distributed by Leading Pharma, LLC in Fairfield, NJ.*

FDA Label Image

Containerlabel10ml (Containerlabel10ml)

This text provides details about Ciprofloxacin Ophthalmic Solution USP 0.3% as base. It includes information on the active ingredients, storage instructions, manufacturer details, and more. This product is indicated for topical ophthalmic use only. The solution contains ciprofloxacin hydrochloride equivalent to ciprofloxacin base 3 mg, as well as benzalkonium chloride as a preservative. For more accurate dosage information, it suggests referring to the enclosed insert. The manufacturer is FDC Limited, located in Maharashtra, India, and the product is distributed by Leading Pharma, LLC, located in Fairfield, NJ.*

FDA Label Image

Containerlabel2point5ml (Containerlabel2point5ml)

This text describes an ophthalmic solution with the active ingredient ciprofloxacin. It contains 0.3% ciprofloxacin as the base. The solution is sterile and for topical ophthalmic use only. The usual dosage information is provided in the enclosed insert. The solution also contains benzalkonium chloride as a preservative. It is manufactured by FDC Limited in Aurangabad, Maharashtra, India. Storage instructions include keeping it at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). Additionally, it mentions the need to protect the content from light and to retain it in the carton until used.*

FDA Label Image

Containerlabel5ml (Containerlabel5ml)

This text provides information about an ophthalmic solution, Ciprofloxacin, containing 0.3% of the active ingredient. The solution is sterile and designed for topical ophthalmic use only. It includes benzalkonium chloride as a preservative and has specific inactive ingredients. The text also mentions the manufacturer and storage instructions. The usual dosage instructions are indicated in the enclosed insert.*

FDA Label Image

Ciprofloxacin Hydrochloride (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 01)

This is not-readable.*

FDA Label Image

Fig 1 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 02)

FDA Label Image

Fig 2 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 03)

FDA Label Image

Fig 2 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 04)

FDA Label Image

Fig 4 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 05)

FDA Label Image

Fig 5 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 06)

FDA Label Image

Fig 6 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 07)

FDA Label Image

Fig 7 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 08)

FDA Label Image

Fig 8 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.